197 related articles for article (PubMed ID: 25499596)
21. MRI-guided wire localization open biopsy is safe and effective for suspicious cancer on breast MRI.
Wang HY; Zhao YN; Wu JZ; Wang Z; Tang JH
Asian Pac J Cancer Prev; 2015; 16(5):1715-8. PubMed ID: 25773814
[TBL] [Abstract][Full Text] [Related]
22. MRI-guided core needle biopsy of the breast: Radiology-pathology correlation and impact on clinical management.
Lilly AJ; Johnson M; Kuzmiak CM; Ollila DW; O'Connor SM; Hertel JD; Calhoun BC
Ann Diagn Pathol; 2020 Oct; 48():151563. PubMed ID: 32738557
[TBL] [Abstract][Full Text] [Related]
23. Pathologic outcomes of nonmalignant papillary breast lesions diagnosed at imaging-guided core needle biopsy.
Holley SO; Appleton CM; Farria DM; Reichert VC; Warrick J; Allred DC; Monsees BS
Radiology; 2012 Nov; 265(2):379-84. PubMed ID: 22952379
[TBL] [Abstract][Full Text] [Related]
24. Frequency of carcinoma at secondary imaging-guided percutaneous breast biopsy performed after a high-risk pathologic result at primary biopsy.
Majewski SA; Zuley ML; Pinnamaneni N; Ganott MA
AJR Am J Roentgenol; 2013 Aug; 201(2):439-47. PubMed ID: 23883227
[TBL] [Abstract][Full Text] [Related]
25. Lesion characteristics, histopathologic results, and follow-up of breast lesions after MRI-guided biopsy.
Taşkın F; Soyder A; Tanyeri A; Öztürk VS; Ünsal A
Diagn Interv Radiol; 2017; 23(5):333-338. PubMed ID: 28830847
[TBL] [Abstract][Full Text] [Related]
26. Why are patients noncompliant with follow-up recommendations after MRI-guided core needle biopsy of suspicious breast lesions?
Thompson MO; Lipson J; Daniel B; Harrigal C; Mullarkey P; Pal S; Thompson AC; Ikeda D
AJR Am J Roentgenol; 2013 Dec; 201(6):1391-400. PubMed ID: 24261382
[TBL] [Abstract][Full Text] [Related]
27. Clinical experience with MRI-guided vacuum-assisted breast biopsy.
Lehman CD; Deperi ER; Peacock S; McDonough MD; Demartini WB; Shook J
AJR Am J Roentgenol; 2005 Jun; 184(6):1782-7. PubMed ID: 15908530
[TBL] [Abstract][Full Text] [Related]
28. Follow-up outcomes after benign concordant MRI-guided breast biopsy.
Hayward JH; Ray KM; Wisner DJ; Joe BN
Clin Imaging; 2016; 40(5):1034-9. PubMed ID: 27348060
[TBL] [Abstract][Full Text] [Related]
29. MRI-guided breast needle core biopsies: pathologic features of newly diagnosed malignancies.
Manion E; Brock JE; Raza S; Reisenbichler ES
Breast J; 2014; 20(5):453-60. PubMed ID: 25040910
[TBL] [Abstract][Full Text] [Related]
30. Underestimation of atypical ductal hyperplasia at MRI-guided 9-gauge vacuum-assisted breast biopsy.
Liberman L; Holland AE; Marjan D; Murray MP; Bartella L; Morris EA; Dershaw DD; Wynn RT
AJR Am J Roentgenol; 2007 Mar; 188(3):684-90. PubMed ID: 17312054
[TBL] [Abstract][Full Text] [Related]
31. PPV(3) of suspicious breast MRI findings.
Smith H; Chetlen AL; Schetter S; Mack J; Watts M; Zhu JJ
Acad Radiol; 2014 Dec; 21(12):1553-62. PubMed ID: 25262952
[TBL] [Abstract][Full Text] [Related]
32. Accuracy of MRI-directed ultrasound and subsequent ultrasound-guided biopsy for suspicious breast MRI findings.
Chikarmane SA; Jin B; Giess CS
Clin Radiol; 2020 Mar; 75(3):185-193. PubMed ID: 31767141
[TBL] [Abstract][Full Text] [Related]
33. MRI-Guided In-Bore Biopsy: Differences Between Prostate Cancer Detection and Localization in Primary and Secondary Biopsy Settings.
Schimmöller L; Blondin D; Arsov C; Rabenalt R; Albers P; Antoch G; Quentin M
AJR Am J Roentgenol; 2016 Jan; 206(1):92-9. PubMed ID: 26700339
[TBL] [Abstract][Full Text] [Related]
34. Unveiling the histopathologic spectrum of MRI-guided breast biopsies: an institutional pathological-radiological correlation.
Moreno G; Molina M; Wu R; Sullivan JR; Jorns JM
Breast Cancer Res Treat; 2021 Jun; 187(3):673-680. PubMed ID: 34043124
[TBL] [Abstract][Full Text] [Related]
35. Nonsurgical management of high-risk lesions diagnosed at core needle biopsy: can malignancy be ruled out safely with breast MRI?
Linda A; Zuiani C; Furlan A; Lorenzon M; Londero V; Girometti R; Bazzocchi M
AJR Am J Roentgenol; 2012 Feb; 198(2):272-80. PubMed ID: 22268168
[TBL] [Abstract][Full Text] [Related]
36. MR imaging-guided 9-gauge vacuum-assisted core-needle breast biopsy: initial experience.
Orel SG; Rosen M; Mies C; Schnall MD
Radiology; 2006 Jan; 238(1):54-61. PubMed ID: 16304093
[TBL] [Abstract][Full Text] [Related]
37. High-spatial-resolution 3-T breast MRI of nonmasslike enhancement lesions: an analysis of their features as significant predictors of malignancy.
Uematsu T; Kasami M
AJR Am J Roentgenol; 2012 May; 198(5):1223-30. PubMed ID: 22528918
[TBL] [Abstract][Full Text] [Related]
38. Management of patients diagnosed with lobular carcinoma in situ at needle core biopsy at a community-based outpatient facility.
Destounis SV; Murphy PF; Seifert PJ; Somerville PA; Arieno AL; Morgan RC; Young WL
AJR Am J Roentgenol; 2012 Feb; 198(2):281-7. PubMed ID: 22268169
[TBL] [Abstract][Full Text] [Related]
39. Outcome of initially only magnetic resonance mammography-detected findings with and without correlate at second-look sonography: distribution according to patient history of breast cancer and lesion size.
Linda A; Zuiani C; Londero V; Bazzocchi M
Breast; 2008 Feb; 17(1):51-7. PubMed ID: 17709249
[TBL] [Abstract][Full Text] [Related]
40. Breast Biopsies Under Magnetic Resonance Imaging Guidance: Challenges of an Essential but Imperfect Technique.
Chevrier MC; David J; Khoury ME; Lalonde L; Labelle M; Trop I
Curr Probl Diagn Radiol; 2016; 45(3):193-204. PubMed ID: 26272705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
